PRODIGE 29-UCGI 26(NEOPAN): A phase III randomised trial comparing chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (LAPC)
ANNÉE
2023
AUTEURS
M.P. Ducreux, R. Desgrippes, Y. Rinaldi, F. Di Fiore, R. guimbaud, L. Evesque, J. Bachet, P. Vanelslander, T. Lecomte, O. Capitain, A. parzy, M. Bolliet, P.L. Etienne, J. Forestier, F. El Hajbi, A.L. Bignon Bretagne, V. Ly Lebrun, N. De Sousa Carvalho, M. Texier, O. Bouche
CONGRÈS/REVUE
ESMO
ÉTUDE
Localisation